Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence
Open Access
- 15 March 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (8), 1414-1423
- https://doi.org/10.1093/rheumatology/ker112
Abstract
Objective. There are limited data on the long-term prognosis of microscopic polyangiitis (MPA). A systematic review was performed to estimate the survival, renal survival and relapse rates in patients with MPA. Methods. Articles included in MEDLINE and EMBASE databases were reviewed. Randomized or non-randomized trials, cohort, case–control and cases-series studies of patients with MPA diagnosed according to Chapel Hill Consensus Conference definitions, a high rate of biopsy-confirmed diagnosis, follow-up >1 year and follow-up losses Results. Eighteen studies for MPA prognosis (n = 940) and six for MPA outcomes after transplantation (n = 65) were included. Survival rates were 77–100% at 1 year, 46–80% at 5 years and 60–80% at 10 years. Higher mortality density occurred within the first months after diagnosis. Vasculitis was the cause of death in 32–50% of patients. Relapses were detected in 19–39% of cases (median time to relapse 15–43 months). Renal graft survival was 85–94% at 1 year and 51–87% at 5 years. Age, renal involvement and immunosuppressive treatment were related to mortality. Lower relapse rate was achieved with 12 vs 6 CYC pulses. Conclusion. Evidence regarding MPA prognosis is weak. MPA mortality is mainly concentrated in the first months after diagnosis. Fewer than 50% of deaths are related to MPA activity. MPA long-term prognosis is less severe, although relapses are frequent. End-stage renal failure is a frequent complication of MPA, and renal transplantation could be an effective therapy in these patients. Early diagnosis, early initiation of a tailored therapy according to risk factors and a longer follow-up of the patients are needed.Keywords
This publication has 39 references indexed in Scilit:
- Microscopic PolyangiitisRheumatic Disease Clinics of North America, 2010
- Treatment of polyarteritis nodosa and microscopic polyangiitis without poor‐prognosis factors: A prospective randomized study of one hundred twenty‐four patientsArthritis & Rheumatism, 2010
- Challenges in the management of microscopic polyangiitis: past, present and futureCurrent Opinion in Rheumatology, 2008
- EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisAnnals Of The Rheumatic Diseases, 2007
- What is new in the therapy of ANCA- associated vasculitides?Take home messages from the 12th workshop on ANCA and systemic vasculitidesClinical Nephrology, 2005
- Deaths Occurring During the First Year After Treatment Onset for Polyarteritis Nodosa, Microscopic Polyangiitis, and Churg-Strauss SyndromeMedicine, 2005
- ANCA-associated renal vasculitis at the end of the twentieth century—a disease of older patientsRheumatology, 2004
- Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidityNephrology Dialysis Transplantation, 2004
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994